| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.74B | 3.41B | 3.15B | 2.81B | 2.17B |
| Gross Profit | 124.10M | 1.10B | 1.49B | 1.09B | 935.30M |
| EBITDA | 316.80M | -250.70M | 235.20M | 82.00M | 215.20M |
| Net Income | -294.30M | -824.10M | -163.80M | -253.60M | -102.00M |
Balance Sheet | |||||
| Total Assets | 2.72B | 3.24B | 4.08B | 4.15B | 4.29B |
| Cash, Cash Equivalents and Short-Term Investments | 406.80M | 244.50M | 356.30M | 291.80M | 508.40M |
| Total Debt | 1.51B | 1.47B | 1.56B | 1.49B | 1.60B |
| Total Liabilities | 2.93B | 3.02B | 3.01B | 2.76B | 2.84B |
| Stockholders Equity | -256.30M | 184.80M | 1.04B | 1.35B | 1.43B |
Cash Flow | |||||
| Free Cash Flow | -59.70M | 63.40M | 88.90M | 41.50M | -42.00M |
| Operating Cash Flow | 109.60M | 259.00M | 230.00M | 221.20M | 170.90M |
| Investing Cash Flow | 44.00M | -190.00M | -103.10M | -180.40M | -197.20M |
| Financing Cash Flow | -81.80M | -157.00M | -62.50M | -202.90M | -113.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.37B | 8.23 | 23.46% | 3.08% | -1.17% | 12.31% | |
71 Outperform | £916.17M | 15.43 | 33.12% | 1.01% | 24.42% | 103.25% | |
71 Outperform | £831.84M | 9.81 | 11.69% | 3.19% | 4.40% | 31.59% | |
64 Neutral | £930.92M | 5.69 | 19.28% | 3.66% | 3.45% | 43.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | £487.27M | 5.91 | 13.04% | 3.18% | 6.55% | 18.44% | |
45 Neutral | £112.30M | -0.48 | 160.47% | ― | -4.74% | -610.71% |